Japan's health ministry announced it has designated cannabis-derived cannabinol (CBN) as a "designated drug," banning its manufacture, import, sale and use starting June 1, except for limited medical purposes. https://www.japantimes.co.jp/news/2026/03/19/japan/society/cbn-ban/?utm_medium=Social&utm_source=mastodon #japan #society #drugs #mhlw
Consumer products containing cannabis-derived CBN to be banned starting June

Under the revised ordinance, only patients with specific conditions, such as intractable diseases with no alternative treatment, will be allowed to use them.

The Japan Times